Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16918-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- HLA-DQA1 antibody
- Antibody type
- Polyclonal
- Description
- HLA-DQA1 antibody (Cat. #16918-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Single-cell transcriptomics reveals the role of antigen presentation in liver metastatic breast cancer.
Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System.
Identification of proteomic signatures associated with COPD frequent exacerbators.
Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China.
Wang X, Zhou Y, Wu Z, Xie C, Xu W, Zhou Q, Yang D, Zhu D, Wang MW, Wang L
iScience 2024 Feb 16;27(2):108896
iScience 2024 Feb 16;27(2):108896
Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System.
Wang X, Zhu H, Lei L, Zhang Y, Tang C, Wu JX, Zhou JR, Xiao XR
Frontiers in genetics 2020;11:581789
Frontiers in genetics 2020;11:581789
Identification of proteomic signatures associated with COPD frequent exacerbators.
Sun P, Ye R, Wang C, Bai S, Zhao L
Life sciences 2019 Aug 1;230:1-9
Life sciences 2019 Aug 1;230:1-9
Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China.
Shen FF, Yue WB, Zhou FY, Pan Y, Zhao XK, Jin Y, Song X, Li B, Han XN, Tang S, Li Y, Yuan G, Chen LS, Liu YL, Hu YL, Li XM, Ren JL, Wang LD
PloS one 2014;9(3):e90438
PloS one 2014;9(3):e90438
No comments: Submit comment
No validations: Submit validation data